Lamour A, Azorin J, Tchandjou Ngoko L E, Valeyre D, Morère F, Destable M D, de Saint-Florent G
Ann Chir. 1989;43(2):133-7.
This work is based on the retrospective study of the case history of 26 patients who were treated between September 1979 and January 1987 in the department of thoracic and vascular surgery at the Avicenne Hospital--and who were all suffering from both lung cancer and atheromatous arterial disease. It is now well established by all the epidemiologic research that the link between lung cancer and atheromatous arterial disease is smoking tobacco. The risks involved in the misunderstanding of such an association are not without danger for the patient, particularly the risk of severe complication of possible coronary or carotid lesions, threatening survival; from this derives the necessity to decide automatically for a minimum of pre-surgery vascular investigations in the case of patients suffering from lung cancer. The therapeutic strategy in this association must be thorough, considering that there are three priorities in the vascular field which must absolutely be treated before the lung itself: --the coronary and carotid lesions which are likely to be complicated cancer after surgery and any state of emergency in the other vascular territories. The fight against tobacco smoking must also be considered as a priority aim.
这项研究基于对1979年9月至1987年1月期间在阿维森纳医院胸血管外科接受治疗的26例患者病历的回顾性研究,这些患者均患有肺癌和动脉粥样硬化性疾病。所有流行病学研究现已充分证实,肺癌与动脉粥样硬化性疾病之间的联系是吸烟。误解这种关联所涉及的风险对患者并非没有危险,特别是可能的冠状动脉或颈动脉病变严重并发症的风险,威胁到生存;因此,对于肺癌患者,有必要自动决定至少进行术前血管检查。这种关联中的治疗策略必须全面,因为在血管领域有三个优先事项必须在肺部手术之前绝对加以治疗:——可能在手术后并发癌症的冠状动脉和颈动脉病变,以及其他血管区域的任何紧急情况。戒烟也必须被视为优先目标。